Dan
@_danielcohen
Followers
589
Following
2K
Statuses
236
president @valence_ai | fmr co-founder & ceo of valence discovery (acquired $RXRX)
Montréal, Québec
Joined August 2017
RT @RecursionPharma: 🎉 It’s a clean sweep! This past weekend at @NeurIPSConf, the world's most prestigious #ML conference, papers from @va…
0
14
0
RT @nathanbenaich: News! @modal_labs is supporting @RAAIS fellowships with $10,000 credits on their platform, alongside the $5,000 GPU cred…
0
34
0
RT @valence_ai: In biology, unpaired data is the norm as experiments are often destructive. This limits our ability to build powerful multi…
0
18
0
RT @RecursionPharma: Announcing the 1st #neuroscience phenomap – “Neuromap” – optioned under our collaboration with @Roche and @Genentech f…
0
42
0
RT @RecursionChris: Huge day for Recursion and for neuroscience - so proud of our team for doing so many world firsts to achieve this and s…
0
10
0
Thanks to everyone who came out, and the teams @valence_ai and @Mila_Quebec for organizing!
In June, we hosted the molecular machine learning conference @Mila_Quebec With 180+ attendees and 45+ posters, it was amazing to see the progress in ML research for drug discovery. Thank you everyone for a great conference! See you at the next MoML 👋
0
1
12
RT @valence_ai: Today, at the ICML workshops, @TOSSOUPrudencio shared some details on our QM data generation efforts and @folinoid discusse…
0
2
0
RT @wpwalters: As someone who has spent a lot of time writing, talking, and complaining about the sad state of benchmarks in our field, I'm…
0
14
0
RT @ENoutahi: 🚀 Polaris is here! It's time to stop overfitting on the same 3 benchmarks in drug discovery.
0
3
0
Benchmarking is hard...but it doesn't have to be! Excited to see @Polaris_HQ launched at #ICML2024 today, w support from an awesome steering committee of industry leaders, to help up-level our collective research community. Excited to get everyone's feedback on this one :)
1/ 🚀Today, we’re excited to launch Polaris! 🚀 Polaris is a platform where the ML community working on drug discovery problems can easily share and access datasets and benchmarks. Get started with just a few lines of code:
0
4
24
The @valence_ai team will be in Vienna for ICML next week. Join us and other TechBio friends at the @Polaris_HQ launch party on Thurs night to learn more :)
Today's benchmarking landscape for ML in drug discovery is complicated. We want to help the community develop methods that matter!🌟 Join us for our launch party at ICML on July 25th to learn more:
1
1
33
1
0
1
RT @zavaindar: “I’m a shareholder, Recursion is the largest investment we’ve ever made .. outside of our own company” - Jensen Huang at (st…
0
17
0
RT @growldnbusiness: Last week our Deputy Mayor for Business and Chair of @londonpartners @howarddawber along with our North American team…
0
8
0
Thanks to everyone who came out and hope to see you again next year!
Sneak peek of the footage we got for the ML4DD summer school 👀 Today was the last day of the summer school. With 150+ participants, it was exciting to see the growing interest of TechBio. Thank you to all of our speakers! See you tomorrow @Mila_Quebec for MoML 2024 👋
0
1
12
RT @tiwarylab: This was so much fun. Lots of very detailed interactions and a very attentive audience. @jonathanhsu @TOSSOUPrudencio and Va…
0
2
0
Thanks to everyone who came out yesterday! Looking forward to sharing more about our work at @raais later today.
Today we opened our office in #London – the epicenter for #TechBio in Europe & home to one of the world’s best talent pools across #tech, #biology and #chemistry. @RecursionChris @howarddawber @mmbronstein @nathanbenaich @zavaindar @valence_ai @KristinaUlicna @_danielcohen
0
2
16
RT @nathanbenaich: not long ago, @recursionpharma and @valence_ai announced the opening of their london office to accelerate ai for drug di…
0
4
0